Cited by

• Improving the Prediction of Potential Kinase Inhibitors with Feature Learning on Multisource Knowledge.

  Zhong Y, Shen C, Wu H, Xu T, Luo L. Zhong Y, et al. Interdiscip Sci. 2022 Sep;14(3):775-785. doi: 10.1007/s12539-022-00523-1. Epub 2022 May 10. Interdiscip Sci. 2022. PMID: 35536538
• Deep Annotation of Donated Chemical Probes (DCP) in Organotypic Human Liver Cultures and Patient-Derived Organoids from Tumor and Normal Colorectum.

  Tredup C, Ndreshkjana B, Schneider NS, Tjaden A, Kemas AM, Youhanna S, Lauschke VM, Berger BT, Krämer A, Berger LM, Röhm S, Knapp S, Farin HF, Müller S. Tredup C, et al. ACS Chem Biol. 2023 Apr 21;18(4):822-836. doi: 10.1021/acschembio.2c00877. Epub 2023 Mar 21. ACS Chem Biol. 2023. PMID: 36944371 Free PMC article.
• Anticancer Profile of Rhodanines: Structure-Activity Relationship (SAR) and Molecular Targets-A Review.

  Szczepański J, Tuszewska H, Trotsko N. Szczepański J, et al. Molecules. 2022 Jun 10;27(12):3750. doi: 10.3390/molecules27123750. Molecules. 2022. PMID: 35744873 Free PMC article. Review.
• A Perspective on Extreme Open Science: Companies Sharing Compounds without Restriction.

  Drewry DH, Wells CI, Zuercher WJ, Willson TM. Drewry DH, et al. SLAS Discov. 2019 Jun;24(5):505-514. doi: 10.1177/2472555219838210. Epub 2019 Apr 29. SLAS Discov. 2019. PMID: 31034310 Free PMC article.
• Design and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A.

  Bourahla K, Guihéneuf S, Limanton E, Paquin L, Le Guével R, Charlier T, Rahmouni M, Durieu E, Lozach O, Carreaux F, Meijer L, Bazureau JP. Bourahla K, et al. Pharmaceuticals (Basel). 2021 Oct 27;14(11):1086. doi: 10.3390/ph14111086. Pharmaceuticals (Basel). 2021. PMID: 34832868 Free PMC article.